Black Diamond Therapeutics, Inc. (BDTX)
Nasdaq: BDTX · Biological Products, (No Diagnostic Substances) · Cambridge, MA · filing with the SEC since 2017
Who runs Black Diamond Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Velleca Mark A.
PRESIDENT & CEO. First filing Aug 2021, latest Jan 23, 2026, 0 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
25 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Velleca Mark A. | PRESIDENT & CEO | Aug 2021 | Jan 23, 2026 | none |
| Jones Erika | Officer Title: Senior Vice President, Finance and Corporate Controller | Nov 2021 | Jan 23, 2026 | none |
| Hatzis-Schoch Brent | Officer Title: Chief Operating Officer and General Counsel | Jan 2020 | Jan 23, 2026 | none |
| Buck Elizabeth | CHIEF SCIENTIFIC OFFICER | Sep 2021 | Jan 23, 2026 | none |
| Yurasov Sergey | CHIEF MEDICAL OFFICER | Jun 2022 | Jan 23, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Behbahani Ali | director | Jan 2020 | Sep 21, 2026 | none |
| Raman Prakash | director | Apr 2024 | Sep 21, 2026 | none |
| Campbell Shannon | director | Apr 2024 | Jun 29, 2026 | none |
| Dhingra Kapil | director | Jan 2021 | Jun 29, 2026 | none |
| Kulkarni Samarth | director | Jan 2020 | Jun 29, 2026 | none |
| Menzel Garry E | director | Jan 2020 | Jun 29, 2026 | none |
Earlier names on the record34, newest filing first
Bb Biotech AG · 10% owner · last filing Mar 2025Biotech Growth N V · 10% owner · last filing Mar 2025Versant Vantage I, L.P. · 10% owner · last filing Aug 2024Versant Venture Capital Vi, L.P. · 10% owner · last filing Aug 2024Versant Voyageurs I Parallel, L.P. · 10% owner · last filing Aug 2024Versant Voyageurs I, L.P. · 10% owner · last filing Aug 2024Dixon Wendy L · director · last filing Apr 2024Ni Fang · officer · last filing Feb 2024Kolchinsky Peter · director · last filing Jul 2023Ra Capital Healthcare Fund LP · director · last filing Jul 2023Ra Capital Management, L.P. · director · last filing Jul 2023Ra Capital Nexus Fund, L.P. · director · last filing Jul 2023Shah Rajeev M. · director · last filing Jul 2023Epstein David M. · officer · last filing Jun 2023Mayweg Alexander · director · last filing May 2023Ingram Robert Alexander · director · last filing Dec 2022Bolzon Bradley J Phd · director · last filing Jun 2021Roberts Christopher D. · officer · last filing May 2021Leggett Thomas · officer · last filing Feb 2021Humphrey Rachel · officer · last filing Feb 2021Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · 10% owner · last filing Feb 2020Deerfield Management Company, L.P. (Series C) · 10% owner · last filing Feb 2020Deerfield Mgmt L.P. · 10% owner · last filing Feb 2020Deerfield Partners, L.P. · 10% owner · last filing Feb 2020Flynn James E · 10% owner · last filing Feb 2020Baskett Forest · 10% owner · last filing Jan 2020Chang Carmen · 10% owner · last filing Jan 2020Florence Anthony A. Jr. · 10% owner · last filing Jan 2020Makhzoumi Mohamad · 10% owner · last filing Jan 2020Makower Joshua · 10% owner · last filing Jan 2020Mott David M · 10% owner · last filing Jan 2020Nea 16 Gp, LLC · 10% owner · last filing Jan 2020Nea Partners 16, L.P. · 10% owner · last filing Jan 2020New Enterprise Associates 16, L.P. · 10% owner · last filing Jan 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.